Tag: Insulin
Cardiometabolic Risk, HOMA-IR Up With Increasing BMI in Young
Cardiorespiratory fitness cuts cardiometabolic risk score as BMI categories rise in children
Insulin Dose Not Tied to Cardiovascular Outcomes
Similar findings among individuals with diabetes able to achieve normoglycemia
Intestinal Glucose Stimulation Has Anti-Incretin Effect
Insulin sensitivity lower during oral versus IV glucose administration; difference amplified in obese
Cognitive Test Predicts Elderly Insulin Injection Success
Number of animal names recalled in one minute was the most useful indicator
In T2D, Glycemic Control Up With Continuous Glucose Monitoring
Improved glycemic control with CGM for patients with T2DM receiving multiple insulin injections daily
Insulin Degludec Linked to Reduced Rate of Hypoglycemia
Reduced rate of hypoglycemic episodes among patients with type 1 diabetes, type 2 diabetes
Genetic, Environmental Exposure Tied to Islet Autoantibodies
Link for male sex; father, sibling as diabetic proband; weight at 12 months with insulin autoantibodies
T1DM Patients With Active β-Cell Function Differ Immunologically
Findings for patients with remaining endogenous β-cell function after 10 or more years of T1DM
ADA: Degludec Noninferior for Cardiovascular Events in T2DM
Noninferior to glargine for incidence of major cardiovascular events in high-risk patients with T2DM
ADA: Glucose Self-Monitoring Often Lacks Benefit in T2DM
No significant improvements in hemoglobin A1c levels, HRQOL seen in non-insulin-treated cases
